United States Computed Tomography (CT) Systems Market Outlook to 2033 - 20-40 slice CT Systems, 64-slice CT Systems and Others

Description

List of Tables

GlobalData's "United States Computed Tomography (CT) Systems Market Outlook to 2033" is a comprehensive databook report, covering key market data on the United States Computed Tomography (CT) Systems market. The databook report provides value (USD), volume (units) and average prices (USD) within market segments - 20-40 slice CT Systems, 64-slice CT Systems and Others

The United States Computed Tomography (CT) Systems Market report provides key information and data on -

Annualized market revenues (USD), volume (units) and average prices (USD) data for each of the market segments. Data is provided from 2018 to 2033.
2023 company share and distribution share data for Computed Tomography (CT) Systems Market.
Global corporate-level profiles of key companies operating within the United States Computed Tomography (CT) Systems Market. Based on the availability of data for the particular category and country, information related to pipeline products, news and deals is also available in the report.

Scope

United States Computed Tomography (CT) Systems is segmented as follows -

16-slice and below CT Systems
20-40 slice CT Systems
64-slice CT Systems
128-slice CT Systems
256-320 slice CT Systems

Reasons to Buy

The United States Computed Tomography (CT) Systems Market report helps you to develop -

Business strategies by identifying the key market segments poised for strong growth in the future.
Market-entry and market expansion strategies.
Design competition strategies by identifying who-stands-where in the market.
Develop investment strategies by identifying the key market segments expected to register strong growth in the near future.
Understand the key distribution channels and what's the most preferred mode of product distribution - Identify, understand and capitalize.

Product Code: GDME1150CCDB

1 Table of Contents

1.1 List of Tables
1.2 List of Figures

2 Introduction

2.1 What Is This Report About?
2.2 Computed Tomography (CT) Systems Market Segmentation
2.3 Definitions of Markets Covered in the Report

3 Computed Tomography (CT) Systems Market, United States

3.1 Computed Tomography (CT) Systems Market, United States, Revenue ($m), 2018-2033
3.2 Computed Tomography (CT) Systems Market, United States, Volume (Units), 2018-2033
3.3 Computed Tomography (CT) Systems Market, United States, Average Price ($), 2018-2033
3.4 Computed Tomography (CT) Systems Market, United States, Distribution Share by Revenue ($m), 2023
3.5 Computed Tomography (CT) Systems Market, United States, Company Share by Revenue ($m), 2023

4 Overview of Key Companies in United States, Computed Tomography (CT) Systems Market

4.1 Siemens Healthineers AG
- 4.1.1 Company Overview
4.2 GE HealthCare Technologies Inc
- 4.2.1 Company Overview
4.3 Philips Healthcare Informatics Inc
- 4.3.1 Company Overview
4.4 Canon Medical Systems Corp
- 4.4.1 Company Overview
4.5 Neusoft Medical Systems Co Ltd
- 4.5.1 Company Overview

5 Computed Tomography (CT) Systems Market Pipeline Products

6 Financial Deals Landscape

6.1 Acquisition
- 6.1.1 Shimadzu Medical Systems USA Acquires California X-ray Imaging Services (California Imaging Services)
- 6.1.2 DirectMed Imaging Acquires Titanium Medical Imaging
6.2 Debt Offerings
- 6.2.1 Stryker Raises USD883.83 Million Public Offering of 3.375% Notes Due 2032
- 6.2.2 Stryker Raises USD662.87 Million in Public Offering of 3.625% Notes Due 2036

7 Recent Developments

7.1 Corporate Communications
- 7.1.1 Sep 23, 2024: OPKO Health's ModeX Therapeutics Appoints Giovanni Abbadessa as Chief Medical Officer as Pipeline Advances into Clinical Development
- 7.1.2 Sep 23, 2024: Accellix Appoints Greg Hamilton as Chief Executive Officer as Company Accelerates Growth in Cell Therapy and Blood Bank Markets
- 7.1.3 May 23, 2024: Magy Seif El-Nasr Appointed the UCSC Presidential Chair
- 7.1.4 Feb 15, 2024: Stephen Agostini Named UCLA's Vice Chancellor and Chief Financial Officer
- 7.1.5 Oct 03, 2023: Vertex Presents VX-880 Results From Phase 1/2 Study in Type 1 Diabetes at the European Association for the Study of Diabetes 59th Annual Meeting
7.2 Financial Announcements
- 7.2.1 Jul 01, 2024: Stryker to Announce Financial Results for its Second Quarter of Fiscal Year 2024
- 7.2.2 Feb 13, 2024: Siemens Announces a 22% Increase in Revenue at 14% Pbt (As A % Of Revenue) In Q1 Fy 2024 Results
- 7.2.3 Jan 18, 2024: GE HealthCare to Announce Fourth Quarter and Full Year 2023 Results on February 6, 2024
- 7.2.4 Oct 02, 2023: Stryker to Announce Financial Results for Its Third Quarter of Fiscal Year 2023
7.3 Government and Public Interest
- 7.3.1 Aug 23, 2024: Moderna Receives Approval for RSV Vaccine mRESVIA
- 7.3.2 Aug 23, 2024: Nurexone Biologic Invited to Present Groundbreaking ExoPTEN Therapy at Prestigious September Conferences
- 7.3.3 Jul 09, 2024: ANEW MEDICAL to Advance Patented Klotho Gene Therapy for Neurodegenerative Disorder Treatments
- 7.3.4 Jun 14, 2024: New Clinical Trial Focuses on Use of Antibody-Drug Conjugate in Neuroendocrine Tumors and Carcinomas
- 7.3.5 May 28, 2024: Phio Pharmaceuticals Announces Positive Recommendation from SMC of Phase 1b Clinical Study of Phio's Lead Compound PH-762
- 7.3.6 May 22, 2024: Accuray to Participate in the Jefferies Global Healthcare Conference 2024
- 7.3.7 Mar 12, 2024: Natera to Present New Data at the 2024 SGO Annual Meeting on Women's Cancer, Following Recent Medicare Coverage Decisions in Ovarian and Breast Cancers
- 7.3.8 Feb 27, 2024: Accuray Incorporated to Speak at Oppenheimer 34th Annual Healthcare MedTech & Services Conference
- 7.3.9 Feb 14, 2024: GE HealthCare Management to Present at Upcoming Investor Conferences
- 7.3.10 Oct 09, 2023: Stryker to Host Investor Day
7.4 Legal And Regulatory
- 7.4.1 Oct 11, 2023: N-Lorem Foundation Convenes First Annual Nano-Rare Patient Colloquium to Share Accomplishments and Learnings in Developing Optimized ASO Therapies
7.5 Other Significant Developments
- 7.5.1 Jul 24, 2024: Sharing Brain Images Can Foster New Neuroscience Discoveries
- 7.5.2 Jun 10, 2024: Unveiling Lung Damage in COVID-19 Patients Using AI
- 7.5.3 Feb 12, 2024: Medicare Coverage Significantly Expanded for the Eversense E3 CGM System
- 7.5.4 Jan 23, 2024: HeartFlow Announces New Reimbursement Code and Increased Payment for FFRCT
- 7.5.5 Jan 03, 2024: Case Western Reserve researchers land $1.1M National Science Foundation grant to advance safer, faster and less expensive medical-imaging technology
7.6 Product News
- 7.6.1 Sep 05, 2024: Ocuphire Pharma Initiates VEGA-3 Phase 3 Trial Evaluating Phentolamine Ophthalmic Solution 0.75% for Presbyopia
- 7.6.2 Sep 04, 2024: Apnimed to Present New Findings on the Prevalence of Obesity Hypoventilation Syndrome (OHS) at the ERS Congress 2024
- 7.6.3 Aug 21, 2024: The STAR Consortium Announces a Major Milestone in Crohn's Disease Intestinal Strictures Imaging
- 7.6.4 Jun 10, 2024: Unveiling Lung Damage in COVID-19 Patients Using AI
- 7.6.5 May 14, 2024: NIH-Funded Study Shows BDI's Bone Density Test Using Existing CT Images Predicts Fractures
- 7.6.6 Apr 25, 2024: Accuray Showcases Advances in Radiation Therapy Solutions Designed to Improve the Cancer Treatment Experience at ESTRO 2024
- 7.6.7 Apr 23, 2024: Crucial Data Solutions Introduces TrialKit PACS to Streamline Image Management in Clinical Trials
- 7.6.8 Mar 23, 2024: Cryoablation Highly Effective for Breast Cancer Patients with Large Tumors
- 7.6.9 Jan 09, 2024: Astellas Provides Update on Zolbetuximab Biologics License Application in U.S.
- 7.6.10 Oct 31, 2023: Context Therapeutics Announces Preclinical Data Demonstrating Differentiated and Active Profile of its Claudin 6-Targeted Bispecific Antibody CTIM-76
7.7 Research And Development
- 7.7.1 Apr 16, 2024: Clinical Trial Looks to Improve Treatment of Early-Stage Breast Cancer
7.8 Strategy And Business Planning
- 7.8.1 Aug 16, 2024: Detect-ION Partners With Moffitt Cancer Center
- 7.8.2 Feb 29, 2024: Aidoc and American College of Cardiology Collaborate to Revolutionize Cardiovascular Care with Best-in-Class AI
- 7.8.3 Dec 05, 2023: OU Health Partners with Siemens Healthineers to Improve Health in Oklahoma, Promote Research, Innovation
- 7.8.4 Oct 02, 2023: RaySearch and Mevion - A Synergy Of Innovation Transforming Proton Therapy

8 Appendix

8.1 Research Methodology
- 8.1.1 Coverage
- 8.1.2 Secondary Research
- 8.1.3 Primary Research
- 8.1.4 Market Modeling and Forecasting
- 8.1.5 Company Share Analysis
- 8.1.6 Distribution Share Analysis
- 8.1.7 Benchmarking
8.2 GlobalData Consulting
8.3 Contact Us
8.4 Disclaimer

Product Code: GDME1150CCDB

List of Tables

Table 1: Computed Tomography (CT) Systems Market, United States, Revenue ($m), USD Constant, 2018-2033
Table 2: Computed Tomography (CT) Systems Market, United States, Volume (Units), 2018-2033
Table 3: Computed Tomography (CT) Systems Market, United States, Average Price ($), 2018-2033
Table 4: Computed Tomography (CT) Systems Market, United States, Distribution Share by Revenue ($m), USD Constant, 2023
Table 5: Computed Tomography (CT) Systems Market, United States, Company Share by Revenue ($m), USD Constant, 2023
Table 6: Computed Tomography (CT) Systems Market Pipeline Products
Table 7: Shimadzu Medical Systems USA Acquires California X-ray Imaging Services (California Imaging Services)
Table 8: DirectMed Imaging Acquires Titanium Medical Imaging
Table 9: Stryker Raises USD883.83 Million Public Offering of 3.375% Notes Due 2032
Table 10: Stryker Raises USD662.87 Million in Public Offering of 3.625% Notes Due 2036
Table 11: Total Number of Primary Research Participants, Diagnostic Imaging Market, by Country

List of Figures

Figure 1: Computed Tomography (CT) Systems Market, United States, Revenue ($m), USD Constant, 2018-2033
Figure 2: Computed Tomography (CT) Systems Market, United States, Volume (Units), 2018-2033
Figure 3: Computed Tomography (CT) Systems Market, United States, Company Share (%) 2023